🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/04/1977 | 1,48 | 1,50 | 1,48 | 1,49 | +1,35% | 1,79% | 4.051.987 |
| 13/04/1977 | 1,46 | 1,48 | 1,45 | 1,47 | +0,46% | 1,81% | 1.795.853 |
| 12/04/1977 | 1,44 | 1,47 | 1,44 | 1,46 | +1,37% | 1,83% | 6.413.760 |
| 11/04/1977 | 1,44 | 1,45 | 1,44 | 1,44 | +0,00% | 0,92% | 1.852.445 |
| 07/04/1977 | 1,44 | 1,45 | 1,43 | 1,44 | +0,24% | 0,92% | 1.856.218 |
| 06/04/1977 | 1,46 | 1,46 | 1,43 | 1,44 | -1,14% | 2,04% | 1.618.531 |
| 05/04/1977 | 1,46 | 1,46 | 1,44 | 1,46 | +0,00% | 1,59% | 2.259.907 |
| 04/04/1977 | 1,48 | 1,48 | 1,45 | 1,46 | -2,00% | 2,45% | 5.014.051 |
| 01/04/1977 | 1,47 | 1,49 | 1,47 | 1,49 | +1,81% | 1,35% | 1.848.672 |
| 31/03/1977 | 1,46 | 1,49 | 1,46 | 1,46 | +0,00% | 2,27% | 1.520.438 |
| 30/03/1977 | 1,51 | 1,51 | 1,46 | 1,46 | -3,29% | 3,51% | 1.403.482 |
| 29/03/1977 | 1,49 | 1,51 | 1,49 | 1,51 | +1,11% | 1,11% | 1.452.528 |
| 28/03/1977 | 1,52 | 1,52 | 1,48 | 1,49 | -2,38% | 2,61% | 5.319.648 |
| 25/03/1977 | 1,54 | 1,55 | 1,53 | 1,53 | -0,85% | 1,50% | 946.973 |
| 24/03/1977 | 1,53 | 1,55 | 1,53 | 1,54 | +0,86% | 1,08% | 2.120.314 |
| 23/03/1977 | 1,53 | 1,54 | 1,52 | 1,53 | -0,22% | 1,08% | 1.437.437 |
| 22/03/1977 | 1,54 | 1,54 | 1,52 | 1,53 | -0,43% | 1,07% | 1.082.794 |
| 21/03/1977 | 1,54 | 1,55 | 1,54 | 1,54 | +0,21% | 1,08% | 1.052.611 |
| 18/03/1977 | 1,55 | 1,56 | 1,54 | 1,54 | -0,86% | 1,28% | 1.150.704 |
| 17/03/1977 | 1,56 | 1,57 | 1,54 | 1,55 | -0,84% | 2,33% | 2.124.086 |
| 16/03/1977 | 1,57 | 1,58 | 1,56 | 1,56 | -0,21% | 1,48% | 3.229.517 |
| 15/03/1977 | 1,56 | 1,58 | 1,56 | 1,57 | +0,85% | 0,85% | 2.557.958 |
| 14/03/1977 | 1,54 | 1,56 | 1,54 | 1,55 | +0,65% | 1,29% | 999.792 |
| 11/03/1977 | 1,53 | 1,54 | 1,53 | 1,54 | +0,86% | 0,65% | 1.701.533 |
| 10/03/1977 | 1,52 | 1,54 | 1,51 | 1,53 | +0,43% | 1,52% | 2.312.726 |
| 09/03/1977 | 1,53 | 1,53 | 1,52 | 1,52 | -0,22% | 0,65% | 1.162.022 |
| 08/03/1977 | 1,54 | 1,55 | 1,53 | 1,53 | -0,64% | 1,51% | 2.282.544 |
| 07/03/1977 | 1,53 | 1,54 | 1,53 | 1,54 | +0,22% | 0,86% | 2.067.494 |
| 04/03/1977 | 1,52 | 1,54 | 1,52 | 1,53 | +0,87% | 0,87% | 1.629.850 |
| 03/03/1977 | 1,50 | 1,52 | 1,49 | 1,52 | +1,55% | 2,00% | 2.052.403 |